Magellan Diagnostics, Inc.
Billerica, MA Part of Meridian Bioscience Inc.
- UEI
- WKK8N9E7BFX9
- CAGE
- 6ZPQ4
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Cincinnati, OH
HWJ5BXUMNGK5
-
Parent
Cincinnati, OH
HWJ5BXUMNGK5
- SAM.gov registration date
- Physical address
- 101 Billerica Ave, North Billerica, MA 01862, USA
- Website
- meridianbioscience.com
- Founded
- 1977
- Employees
- 251-1K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
SBA capabilities narrative
Medical device company that provides point-of-care systems, clinical laboratory instruments, and analytical laboratory services focused on lead testing.
Quick answers
Is Magellan Diagnostics, Inc. registered in SAM.gov?
Yes. Magellan Diagnostics, Inc.'s SAM.gov registration is active through March 9, 2027.
What is Magellan Diagnostics, Inc.'s most recent federal award?
Magellan Diagnostics, Inc.'s most recent federal contract award is Magellan diagnostics lead i & II test kits (75D30118P03169), from CDC Pittsburgh, on August 29, 2018.
On GovTribe
See Magellan Diagnostics, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors